UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
(Mark One)
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the Quarterly Period Ended June 30, 2004
or
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the Transition Period from _______ to ________
Commission File Number: 1-11008
CATALINA MARKETING CORPORATION
| Delaware (State or Other Jurisdiction of Incorporation or Organization) 200 Carillon Parkway, St. Petersburg, Florida (Address of Principal Executive Offices) |
33-0499007 (IRS Employer Identification Number) 33716-2325 (Zip Code) |
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days. Yes o No x
Indicate by checkmark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes x No o
At July 31, 2004, the Registrant had outstanding 52,141,234 shares of Common Stock.
CATALINA MARKETING CORPORATION
INDEX
2
Part I. Financial Information
References herein to Catalina Marketing, the Company, we, us or our refer to Catalina Marketing Corporation and its subsidiaries, unless the context specifically states or implies otherwise.
Item 1. Financial Statements
CATALINA MARKETING CORPORATION
| Three Months Ended June 30, |
||||||||
| 2004 |
2003 |
|||||||
Revenues |
$ | 105,643 | $ | 102,212 | ||||
Costs and expenses: |
||||||||
Direct operating expenses |
41,678 | 46,805 | ||||||
Selling, general and administrative |
31,771 | 35,619 | ||||||
Impairment charge |
1,609 | | ||||||
Depreciation and amortization |
12,198 | 11,804 | ||||||
Total costs and expenses |
87,256 | 94,228 | ||||||
Income from operations |
18,387 | 7,984 | ||||||
Interest expense |
(612 | ) | (529 | ) | ||||
Other income (expenses), net |
192 | 727 | ||||||
Income before income taxes |
17,967 | 8,182 | ||||||
Provision for income taxes |
7,041 | 3,149 | ||||||
Income before cumulative effect of accounting
change |
10,926 | 5,033 | ||||||
Cumulative effect of accounting change, net of
$0.6 million tax benefit |
| (770 | ) | |||||
Net income |
$ | 10,926 | $ | 4,263 | ||||
Basic: |
||||||||
Net income per common share before cumulative
effect of accounting change |
$ | 0.21 | $ | 0.10 | ||||
Cumulative effect of accounting change |
| (0.02 | ) | |||||
Net income per common share |
$ | 0.21 | $ | 0.08 | ||||
Weighted average common shares outstanding |
52,227 | 52,536 | ||||||
Diluted: |
||||||||
Net income per common share before cumulative
effect of accounting change |
$ | 0.21 | $ | 0.10 | ||||
Cumulative effect of accounting change |
| (0.02 | ) | |||||
Net income per common share |
$ | 0.21 | $ | 0.08 | ||||
Weighted average common shares outstanding |
52,245 | 52,569 | ||||||
See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.
3
CATALINA MARKETING CORPORATION
| June 30, | March 31, | |||||||
| 2004 |
2004 |
|||||||
ASSETS |
||||||||
Current Assets: |
||||||||
Cash and cash equivalents |
$ | 71,467 | $ | 72,704 | ||||
Accounts receivable, net |
64,402 | 56,963 | ||||||
Inventory |
5,734 | 5,836 | ||||||
Deferred tax asset |
8,454 | 8,536 | ||||||
Prepaid expenses and other current assets |
15,685 | 14,958 | ||||||
Total current assets |
165,742 | 158,997 | ||||||
Property and equipment: |
||||||||
Property and equipment |
376,808 | 381,999 | ||||||
Less accumulated depreciation and amortization |
(260,189 | ) | (255,156 | ) | ||||
Property and equipment, net |
116,619 | 126,843 | ||||||
Patents, net |
12,992 | 13,472 | ||||||
Goodwill |
83,134 | 84,743 | ||||||
Other assets |
2,583 | 2,754 | ||||||
Total assets |
$ | 381,070 | $ | 386,809 | ||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
Current Liabilities: |
||||||||
Accounts payable |
$ | 13,789 | $ | 15,372 | ||||
Accrued expenses |
50,884 | 65,778 | ||||||
Income taxes payable |
3,083 | 3,127 | ||||||
Deferred revenue |
36,389 | 35,730 | ||||||
Short-term borrowings |
36,858 | 37,016 | ||||||
Total current liabilities |
141,003 | 157,023 | ||||||
Long-term deferred tax liability |
10,104 | 9,827 | ||||||
Long-term debt |
29,913 | 29,908 | ||||||
Other long-term liabilities |
4,468 | 4,475 | ||||||
Total liabilities |
185,488 | 201,233 | ||||||
Commitments and contingencies
|
||||||||
Minority interest |
914 | 914 | ||||||
Stockholders Equity: |
||||||||
Preferred stock; $0.01 par value; 5,000,000
authorized shares; none issued and outstanding |
| | ||||||
Common stock; $0.01 par value; 150,000,000
authorized shares and 52,140,866 and 52,134,462
shares issued and outstanding at
June 30, 2004 and March 31, 2004, respectively |
521 | 521 | ||||||
Paid-in capital |
2,561 | 2,485 | ||||||
Accumulated other comprehensive loss |
(1,308 | ) | (312 | ) | ||||
Retained earnings |
192,894 | 181,968 | ||||||
Total stockholders equity |
194,668 | 184,662 | ||||||
Total liabilities and stockholders equity |
$ | 381,070 | $ | 386,809 | ||||
See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.
4
CATALINA MARKETING CORPORATION
| Par | Accumulated | |||||||||||||||||||||||||||
| Number | Value of | Other | Total | |||||||||||||||||||||||||
| Comprehensive | of | Common | Paid-in | Comprehensive | Retained | Stockholders' | ||||||||||||||||||||||
| Income |
Shares |
Stock |
Capital |
Loss |
Earnings |
Equity |
||||||||||||||||||||||
BALANCE AT MARCH 31, 2004 |
52,134 | $ | 521 | $ | 2,485 | $ | (312 | ) | $ | 181,968 | $ | 184,662 | ||||||||||||||||
Deferred compensation plan common stock
units and Directors common stock grants |
7 | | 76 | | | 76 | ||||||||||||||||||||||
Net income |
$ | 10,926 | | | | | 10,926 | 10,926 | ||||||||||||||||||||
Foreign currency translation adjustment |
(996 | ) | | | | (996 | ) | | (996 | ) | ||||||||||||||||||
Comprehensive income |
9,330 | | | | | | | |||||||||||||||||||||
BALANCE AT JUNE 30, 2004 |
52,141 | $ | 521 | $ | 2,561 | $ | (1,308 | ) | $ | 192,894 | $ | 194,668 | ||||||||||||||||
See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.
5
CATALINA MARKETING CORPORATION
| Three Months Ended June 30, |
||||||||
| 2004 |
2003 |
|||||||
Net cash provided by operating activities: |
$ | 1,866 | $ | 17,279 | ||||
Cash flows from investing activities: |
||||||||
Capital expenditures |
(2,141 | ) | (9,664 | ) | ||||
Cash flows from financing activities: |
||||||||
Proceeds from the Corporate Facility, net |
| 10,000 | ||||||
Proceeds from Japan borrowings |
| 3,963 | ||||||
Principal payments on Japan borrowings |
(698 | ) | (1,678 | ) | ||||
Repurchases of Company common stock |
| (13,307 | ) | |||||
Proceeds from the issuance of common and
subsidiary stock |
| 714 | ||||||
Net cash used in financing activities |
(698 | ) | (308 | ) | ||||
Effect of exchange rate changes on cash and cash
equivalents |
(264 | ) | (136 | ) | ||||
Net change in cash and cash equivalents |
(1,237 | ) | 7,171 | |||||
Cash and cash equivalents at end of prior period |
72,704 | 1,715 | ||||||
Cash and cash equivalents at end of current period |
$ | 71,467 | $ | 8,886 | ||||
See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.
6
CATALINA MARKETING CORPORATION
Note 1. Description of the Business and Basis for Presentation
Description of the Business. Catalina Marketing Corporation, a Delaware corporation, and its subsidiaries (the Company), provides behavior-based communications, developed and distributed for consumer packaged goods manufacturers, pharmaceutical manufacturers and marketers, and retailers. The Companys primary business initially was developed to provide consumers with in-store coupons delivered based upon purchase behavior and distributed primarily in supermarkets. Today, the Company offers behavior-based, targeted-marketing services and programs globally through a variety of distribution channels. These marketing solutions, including discount coupons, loyalty marketing programs, pharmacist and patient education newsletters, compliance mailings, pharmacy counter mats, attitudinal research programs, sampling, advertising, in-store instant-win games and other consumer communications, are delivered directly to shoppers by various means. By specifying how a particular consumer transaction will trigger a promotion to print, manufacturers and retailers can deliver customized incentives and messages to only the consumers they wish to reach. The Company tracks actual purchase behavior and primarily uses Universal Product Code-based scanner technology to target consumers at the checkout counter and National Drug Code information to trigger delivery of a customized communication to consumers during pharmacy prescription checkout transactions.
The Company is organized and managed by segments, which include the following operations: Catalina Marketing Services (CMS), Catalina Health Resource (CHR), the International operations, which includes services similar to those provided in the United States by CMS (International), Japan Billboard, a billboard and outdoor media business operated in Japan (Japan Billboard), Direct Marketing Services (DMS) and Catalina Marketing Research Solutions (CMRS). The domestic operations of the Company include CMS, CHR, DMS and CMRS. The international operations of the Company are organized and managed by country and include International and Japan Billboard. In November 2003, the Company announced its intent to divest of DMS, CMRS and Japan Billboard which were deemed not to be strategically aligned with the Companys current core competencies. See further discussion in the Companys Annual Report on Form 10-K for the fiscal year ended March 31, 2004, filed with the United States Securities and Exchange Commission (SEC) on July 15, 2004. Although these segments have been targeted for divestiture by the Company, the results of operations for these segments are reflected in continuing operations in our unaudited condensed consolidated financial statements. The Company has concluded that these businesses do not qualify for held for sale treatment at June 30, 2004, pursuant to Statement of Financial Accounting Standard (SFAS) No. 144, Accounting for the Impairment of Long-lived Assets.
The Company previously reported the activities of the operating segments Retail Services and CMRS in Other. Effective April 1, 2004, the Company restructured the Retail Services and Manufacturer Services units by merging Retail Services into Manufacturer Services and renaming the segment Catalina Marketing Services, or CMS. The restructuring was part of the Companys strategy to optimize its selling and administrative efforts. As a result of the restructuring, Retail Services is no longer reported as a separate business segment. Segment information for the three months ended June 30, 2003 for Retail Services has been reclassified to CMS to reflect the new segment reporting.
CMS serves the needs of domestic consumer product manufacturers, primarily within the consumer packaged goods industry, and the grocery retail industry. Using the Catalina Marketing Network®, this operating segment specializes in behavior-based marketing communications that are delivered at the point-of-sale. The primary service line of the Catalina Marketing Network® is the in-store delivery of promotions at the checkout lane of a retailer, typically a supermarket. Catalina Marketing links its proprietary software, computers, central databases and thermal printers with a retailers point-of-sale controllers and scanners. The network prints customized promotions at the point-of-sale based on product Universal Product Codes or other scanned information. The printed promotions are handed to consumers by the cashier at the end of the shopping transaction. CMS also provides marketing solutions to retail chains nationwide and supports and maintains the Catalina Marketing Network®.
CHR services allow pharmaceutical and consumer packaged goods manufacturers, as well as retail pharmacies, to provide consumers with condition-specific health information and direct-to-patient communications. CHRs primary product offerings use an in-store, prescription-based targeting technology to provide targeted, direct-to-patient communications on behalf of the Companys clients. These communication services include messages and educational information to healthcare patients at the pharmacy level throughout the Health Resource Network. The Health Resource Network is a proprietary software system with built-in targeted response capabilities.
7
Communications are primarily delivered to patients based on prescription medications purchased which are identified by a National Drug Code symbol. Clients are able to use these communications to provide information on a wide variety of products such as over-the- counter medicines, prescription medication and other healthcare remedies and merchandise. Communications provide clinically appropriate information while maintaining patient privacy.
International operations include in-store electronic targeted marketing services for consumers in France, Italy, the United Kingdom, Germany and Japan. The Catalina Marketing Network® operates internationally in a similar manner as the domestic business and offers a full range of targeted marketing solutions to consumer packaged goods manufacturers and enjoys relationships with supermarket, hypermarket and other retailers.
Japan Billboard is a wholly owned subsidiary of the Company that operates a billboard and outdoor media business in Japan. Japan Billboard primarily owns and rents billboards which are displayed on rooftops or faces of buildings in locations suitable for advertising.
DMS provides services designed to reach consumers in their homes. DMS analyzes frequent shopper databases and identifies consumer lifestyle changes to develop strategic programs that meet multiple objectives for both brand manufacturers and retailers. These targeted direct mail programs are based on actual purchase behavior or consumer lifestyle changes. DMS provides services which enable manufacturers and retailers to influence the purchase patterns of targeted customers based on their actual purchase behavior and history. Clients use these services to support new product launches and line extensions, build loyalty to a brand and deliver timely messages to consumers.
CMRS provides a wide range of traditional marketing research services, including tracking studies and other satisfaction surveys, as well as proprietary research products that take advantage of behavioral data gathered throughout the Catalina Marketing Network®.
Delay in Filing Our Annual Report and Quarterly Financial Results for the Fiscal Year Ended March 31, 2004. In June 2004, we announced our intent to delay the filing of our Annual Report on Form 10-K for the fiscal year ended March 31, 2004. In addition, the Company was unable to file its Quarterly Report on Form 10-Q for the quarters ended June 30, 2003, September 30, 2003 and December 31, 2003 in a timely manner. As required, Catalina filed notifications of late filing with the SEC under Rule 12b-25 for these filings. The Company filed its Annual Report on Form 10-K for fiscal year 2004 on July 15, 2004. The Annual Report on Form 10-K for fiscal year 2004 filing was delayed because of the significant time and resources required to file the Companys Annual Report on Form 10-K for fiscal year 2003, which was filed on May 17, 2004.
The Company is filing this Quarterly Report on Form 10-Q for the quarter ended June 30, 2004 today and expects to file a Quarterly Report on Form 10-Q for each of the quarters ended September 30, 2003 and December 31, 2003 for the immediately preceding fiscal year ended March 31, 2004, as soon as practicable. The unaudited condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and notes thereto included in the Companys Annual Report on Form 10-K for the fiscal year ended March 31, 2004, filed with the SEC on July 15, 2004.
In this Form 10-Q for the quarterly period ended June 30, 2004, words such as today, current or currently, or phrases such as as of the date hereof or as of the date of this report, refer to the date this Quarterly Report on Form 10-Q is filed with the SEC.
Basis of Presentation. These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes as required by accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments, consisting only of normal recurring accruals, except as disclosed herein, considered necessary for a fair presentation of the financial position of the Company as of June 30, 2004, the results of its operations and cash flows for the three-month periods ended June 30, 2004 and 2003, and the results of its changes in stockholders equity for the three-month period ended June 30, 2004 have been included.
The balance sheet at March 31, 2004 has been derived from the audited financial statements at that date but does not include all of the information or notes required by accounting principles generally accepted in the United States of America for complete financial statements. Operating results for the three-month period ended June 30, 2004 are not necessarily indicative of the results that may be expected for the remainder of the year ending March 31, 2005.
8
The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned and majority owned subsidiaries. All significant intercompany transactions are eliminated in consolidation. In addition, the unaudited condensed consolidated financial statements include the accounts of a variable interest entity from which the Company leases its headquarters facility in St. Petersburg, Florida. The Company has determined that it is the primary beneficiary of this entity and, thus, has included the accounts of this entity in its unaudited condensed consolidated financial statements pursuant to the requirements of the Financial Accounting Standards Boards (FASB) Interpretation (FIN) No. 46 (revised 2003), Consolidation of Variable Interest EntitiesAn Interpretation of ARB No. 51. The accounts of the wholly and majority owned foreign subsidiaries are included on a three-month lag, (i.e., for the three-month periods ended March 31, 2004 and March 31, 2003), to facilitate the timing of the Companys closing process.
Note 2. Stock Based Compensation
The Company applies the recognition and measurement principles of APB Opinion No. 25 and related interpretations in accounting for its stock-based employee compensation plans. Additionally, the Company has adopted the disclosure provisions of SFAS No. 148, Accounting for Stock-Based Compensation-Transition and Disclosure, which amends SFAS No. 123, Accounting for Stock-Based Compensation. SFAS No. 148 allows for the continued use of the recognition and measurement principles of APB Opinion No. 25 and related interpretations in accounting for those plans. The following table illustrates the effect on net income and earnings per share if the Company had applied the fair value recognition provisions to stock-based employee compensation. Such disclosure is not necessarily indicative of the fair value of stock options that could be granted by the Company in future fiscal years or of the value of all options currently outstanding. The pro forma results were calculated with the use of the Black-Scholes option-pricing model. Had compensation expense for these plans been recognized in accordance with SFAS No. 123, the Companys net income and earnings per share would have been reduced to the following pro forma amounts (in thousands, except per share data):
| Three Months Ended June 30, |
||||||||
| 2004 |
2003 |
|||||||
Net income: |
||||||||
As reported |
$ | 10,926 | $ | 4,263 | ||||
Add stock-based employee compensation expense
included in reported net income, net of tax |
76 | 37 | ||||||
Deduct total stock-based employee compensation
expense determined under fair value based method
for all awards, net of tax |
(3,608 | ) | (1,808 | ) | ||||
Pro forma net income |
$ | 7,394 | $ | 2,492 | ||||
Basic EPS: |
||||||||
As reported |
$ | 0.21 | $ | 0.08 | ||||
Pro forma |
$ | 0.14 | $ | 0.05 | ||||
Diluted EPS: |
||||||||
As reported |
$ | 0.21 | $ | 0.08 | ||||
Pro forma |
$ | 0.14 | $ | 0.05 | ||||
Pro forma amounts include approximately $0.4 million related to the purchase discount offered under the Purchase Plan for the three months ended June 30, 2003. There were no shares issued under the Purchase Plan for the three months ended June 30, 2004, and, consequently, no accompanying purchase discount.
During the three months ended June 30, 2003, certain of the Companys executives left the Company prior to exercising their options and, as a result, any unexercised options have been forfeited. The pro forma compensation expense for the first quarter of fiscal year 2004 shown in the table above includes a reversal of previously reported pro forma compensation expense of $3.9 million, net of a tax benefit of $2.4 million, related to these forfeited options.
9
Note 3. Accounting Standards Adopted During the Three Months Ended June 30, 2004
Revised SFAS No. 132. In December 2003, the FASB issued a revision to Statement of Financial Accounting Standards No. 132 (SFAS No. 132). This revision to SFAS No. 132 is intended to improve financial statement disclosures for defined benefit plans and was initiated in response to concerns raised by investors and other users of financial statements about the need for greater transparency of pension information. In particular, the standard requires that companies provide more details in their interim financial reports about their net periodic pension expense and amounts expected to be paid to the plan during the current fiscal year.
In fiscal year 2002, the Company implemented a plan to provide healthcare benefits to certain eligible retirees and active employees and their eligible dependents. The plan contains no assets, and the Company does not anticipate making contributions to the plan, other than for current benefit payments. Benefits are funded from the Companys assets on a current basis. Plan benefits are subject to co-payments, deductibles, and other limits as defined by the plan. Benefits paid during the three months ended June 30, 2004 and 2003 were not material. The Companys funding of the cost of healthcare benefits is at the discretion of management. A detail of net periodic expense for the three months ended June 30, 2004 and 2003 is as follows:
| Three Months Ended June 30, |
||||||||
| 2004 |
2003 |
|||||||
Service cost |
$ | | $ | 3 | ||||
Interest cost |
31 | 32 | ||||||
Amortization of unrecognized prior service costs |
| 111 | ||||||
| $ | 31 | $ | 146 | |||||
The revision to SFAS No. 132 also requires additional disclosures on an annual basis. The annual disclosures required under SFAS No. 132 as they related to the Companys postretirement healthcare plan have been provided in Note 15 to the Companys Consolidated Financial Statements as filed in its Annual Report on Form 10-K for fiscal year ended March 31, 2004.
Note 4. Net Income Per Common Share
The following is a reconciliation of the denominator of basic earnings per share (EPS) to the denominator of diluted EPS (in thousands):
| Three Months Ended June 30, |
||||||||
| 2004 |
2003 |
|||||||
Basic weighted average common shares outstanding |
52,227 | 52,536 | ||||||
Dilutive effect of options outstanding |
18 | 33 | ||||||
Diluted weighted average common shares
outstanding |
52,245 | 52,569 | ||||||
Options to purchase 4,097,985 shares of common stock at exercise prices ranging from $18.13 to $36.82 per share for the three months ended June 30, 2004, and 7,221,272 shares at exercise prices ranging from $18.13 to $36.82 per share for the three months ended June 30, 2003 were not included in the computation of diluted EPS for the respective period because their exercise prices were greater than the average market price of common stock during the relevant periods.
Note 5. Comprehensive Income (in thousands)
| Three months ended June 30, |
||||||||
| 2004 |
2003 |
|||||||
Net income |
$ | 10,926 | $ | 4,263 | ||||
Other comprehensive loss, net of tax: |
||||||||
Currency translation adjustment |
(996 | ) | (542 | ) | ||||
Comprehensive Income |
$ | 9,930 | $ | 3,721 | ||||
10
Note 6. Segment Information
The Company is organized and managed by segments, as described in following table:
| Segment |
Business Activity |
|
Catalina Marketing Services
|
Provides point-of-sale, printed promotions to consumers for consumer packaged goods manufacturers and our retail partners. | |
Catalina Health Resource
|
Provides point-of-sale printed direct-to-patient communications for pharmaceutical and consumer packaged goods manufacturers and retailers. | |
International
|
Provides services similar to Catalina Marketing Services in the United Kingdom, France, Italy, Germany and Japan. | |
Japan Billboard
|
Provides billboards and outdoor media advertising in Japan. | |
Direct Marketing Services
|
Provides direct mail services to consumers homes for manufacturing and retail clients. | |
Catalina Marketing Research Solutions
|
Provides traditional marketing research services. | |
Corporate
|
Provides executive and administrative oversight and centralized functions such as information technology, client services and store systems support. |
The Company previously reported the activities of the operating segments Retail Services and CMRS in Other. Effective April 1, 2004, the Company restructured the Retail Services and Manufacturer Services units by merging Retail Services into Manufacturer Services and renaming the segment Catalina Marketing Services, or CMS. The restructuring was part of the Companys strategy to optimize its selling and administrative efforts. As a result of the restructuring, Retail Services is no longer reported as a separate business segment. Segment information for the three months ended June 30, 2003 for Retail Services has been reclassified to CMS to reflect the new segment reporting.
Financial information for each of the Companys reportable segments is presented in the following tables.
| Revenues from | ||||||||||||||||||||
| External | Intersegment | |||||||||||||||||||
| Customers |
Revenues |
|||||||||||||||||||
| Three Months Ended June 30, |
||||||||||||||||||||
| Segments: |
2004 |
2003 |
2004 |
2003 |
||||||||||||||||
Catalina Marketing Services |
$ | 63,398 | $ | 59,599 | $ | 4 | $ | | ||||||||||||
Catalina Health Resource |
17,866 | 14,466 | | | ||||||||||||||||
International |
14,246 | 9,111 | | | ||||||||||||||||
Direct Marketing Services |
5,800 | 11,657 | 138 | 155 | ||||||||||||||||
Japan Billboard |
2,921 | 3,768 | | | ||||||||||||||||
Catalina Marketing Research Solutions |
1,342 | 3,576 | 40 | 191 | ||||||||||||||||
| 105,573 | 102,177 | 182 | 346 | |||||||||||||||||
Reconciliation of segments
to consolidated amount: |
||||||||||||||||||||
Corporate |
70 | 35 | 696 | 435 | ||||||||||||||||
Eliminations |
| | (878 | ) | (781 | ) | ||||||||||||||
| $ | 105,643 | $ | 102,212 | $ | | $ | | |||||||||||||
11
| Net Income (Loss) |
||||||||
| Three Months Ended June 30, |
||||||||
| Segments: |
2004 |
2003 |
||||||
Catalina Marketing Services |
$ | 16,133 | $ | 12,836 | ||||
Catalina Health Resource |
1,074 | (1,997 | ) | |||||
International |
801 | (1,146 | ) | |||||
Direct Marketing Services |
(1,819 | ) | (483 | ) | ||||
Japan Billboard |
(181 | ) | (1,138 | ) | ||||
Catalina Marketing Research Solutions |
(437 | ) | 274 | |||||
Reconciliation of segments to consolidated amount: |
||||||||
Corporate |
(4,645 | ) | (4,083 | ) | ||||
Consolidated |
$ | 10,926 | $ | 4,263 | ||||
| Total Assets |
||||||||
| Segments: |
June 30, 2004 |
March 31, 2004 |
||||||
Catalina Marketing Services |
$ | 1,149,055 | $ | 1,514,933 | ||||
Catalina Health Resource |
65,515 | 68,284 | ||||||
International |
95,519 | 98,039 | ||||||
Direct Marketing Services |
41,789 | 45,788 | ||||||
Japan Billboard |
6,018 | 6,654 | ||||||
Catalina Marketing Research Solutions |
7,988 | 10,963 | ||||||
Reconciliation of segments to consolidated
amount: |
||||||||
Eliminations |
(1,399,771 | ) | (2,277,109 | ) | ||||
Corporate |
414,957 | 919,257 | ||||||
| $ | 381,070 | $ | 386,809 | |||||
Note 7. Impairment Charges and Goodwill
The accompanying unaudited condensed consolidated statements of income reflect an impairment charge of $1.6 million for the three months ended June 30, 2004. In November 2003, the Company announced its intent to divest DMS. As a result, the Company tested the goodwill of this reporting unit for impairment during fiscal year 2004, resulting in partial impairment of goodwill. The Company tested the goodwill at DMS for impairment again during the three months ended June 30, 2004 due to a further decline in DMS forecasted cash flows. Based upon this testing, the Company determined that an additional impairment of goodwill had occurred and recorded an impairment charge of $1.6 million, reducing the goodwill attributable to this business unit to $0 as of June 30, 2004.
Changes in the carrying amount of goodwill, including the effect of impairment charges through June 30, 2004, were as follows:
| CMS |
&n | |||||||||||||||||||||||